Last update 08 May 2025

SKP-0110

Overview

Basic Info

Drug Type
Immunoglobulin
Synonyms
Intravenous immunoglobulin 10%
Target-
Action-
Mechanism-
Therapeutic Areas-
Active Indication-
Inactive Indication-
Originator Organization
SK Plasma Co., Ltd.SK Plasma Co., Ltd.
Active Organization
SK Plasma Co., Ltd.SK Plasma Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseClinical
First Approval Date-
Regulation-

Related

10
Clinical Trials associated with SKP-0110
ISRCTN69615004
/ RecruitingPhase 3IIT
Intravenous immunoglobulin in autoimmune encephalitis in adults – a randomised double-blind placebo-controlled trial
EUCTR2020-001710-37-NL
/ Unknown statusPhase 3IIT
Intravenous immunoglobulin and prednisone vs. prednisone in newly diagnosed myositis: a double blind randomized clinical trial. - IVIG in myositis: TIME IS MUSCLE
JPRN-jRCTs041190028
/ Not yet recruitingNot ApplicableIIT
Intravenous Immunoglobulin Therapy for Amyotrophic lateral sclerosis - ALSIvig
100 Clinical Results associated with SKP-0110
Login to view more data
100 Translational Medicine associated with SKP-0110
Login to view more data
100 Patents (Medical) associated with SKP-0110
Login to view more data
100 Deals associated with SKP-0110
Login to view more data

R&D Status

Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
ISC2014
Phase 1
Subarachnoid Hemorrhage
23
byrhkcgovk(qfsmgdubdm) = hvqmqshjjm pdcpzcyydo (mvsdrqssrk )
-
01 Feb 2014
byrhkcgovk(qfsmgdubdm) = kwhhivphcd pdcpzcyydo (mvsdrqssrk )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free